Virtus LifeSci Biotech Clinical Trials ETF
15 hedge funds and large institutions have $4.78M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$530K | |
| 2 | -$338K | |
| 3 | -$149K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$28.8K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$6K |